InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,307.74
(
-0.01%
)
US TECH 100
18,149.60
(
-0.26%
)
Dow Jones
39,863.12
(
0.14%
)
Brent Oil
82.69
(
-1.01%
)
Bitcoin
70,802.14
(
-0.91%
)
Post# of 251868
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119663
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Mufaso post# 250081

Monday, 01/08/2024 6:32:22 PM

Monday, January 08, 2024 6:32:22 PM

Post# of 251868
PFE has an oral *non*-GLP-1 anti-obesity drug in phase-1, according to today’s JPM webcast. For competitive reasons, PFE is not disclosing the MoA. (I am not referring to PF-06954522, which is an oral GLP-1 in phase-1.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up